PT Siloam International Hospitals Tbk (FRA:2LS) Total Stockholders Equity: €509.8 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2LS PT Siloam International Hospitals Tbk FRA:2LS
91 GF Score
Price €0.10
GF Value €0.12
! 2 Warning Signs
View Full Analysis

What is PT Siloam International Hospitals Tbk Total Stockholders Equity?

PT Siloam International Hospitals Tbk FRA:2LS 91 Total Stockholders Equity is €509.8 Mil as of Mar. 2026. GuruFocus rates FRA:2LS with a GF Score™ of 91/100 and a GF Value™ of €0.12. The stock has 2 warning signs investors should review.

PT Siloam International Hospitals Tbk's Total Stockholders Equity for the quarter that ended in Mar. 2026 was €509.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PT Siloam International Hospitals Tbk's Book Value per Share for the quarter that ended in Mar. 2026 was €0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PT Siloam International Hospitals Tbk's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.21.


PT Siloam International Hospitals Tbk  (FRA:2LS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PT Siloam International Hospitals Tbk's Book Value per Share for the quarter that ended in Mar. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PT Siloam International Hospitals Tbk's Debt-to-Equity for the quarter that ended in Mar. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Siloam International Hospitals Tbk Total Stockholders Equity Related Terms


PT Siloam International Hospitals Tbk Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for PT Siloam International Hospitals Tbk's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Siloam International Hospitals Tbk Total Stockholders Equity Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.89 420.49 467.84 510.37 495.61

PT Siloam International Hospitals Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 495.72 480.96 482.83 495.61 509.80
FRA:2LS
91GF Score
PT Siloam International Hospitals Tbk FRA:2LS
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €509.8 Mil mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Total Stockholders Equity of €509.8 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for PT Siloam International Hospitals Tbk and its competitors.
Is PT Siloam International Hospitals Tbk's Total Stockholders Equity too high?
PT Siloam International Hospitals Tbk's current Total Stockholders Equity is €509.8 Mil. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Total Stockholders Equity compare to HCA and THC?
PT Siloam International Hospitals Tbk's Total Stockholders Equity of €509.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for PT Siloam International Hospitals Tbk and its competitors. PT Siloam International Hospitals Tbk's current Total Stockholders Equity is €509.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
PT Siloam International Hospitals Tbk (FRA:2LS) has a current Total Stockholders Equity of €509.8 Mil. The stock's GF Value™ is €0.12, compared to a current price of €0.10 — trading 19.6% below its estimated fair value. The current Total Stockholders Equity is €509.8 Mil. PT Siloam International Hospitals Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Total Stockholders Equity is €509.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued. The current stock price of €0.10 is trading 19.6% below its estimated GF Value™ of €0.12.

Key valuation signals for FRA:2LS:

  • Total Stockholders Equity: €509.8 Mil
  • GF Value™: €0.12 vs. price of €0.10 (19.6% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Siloam International Hospitals Tbk Business Description

Other Exchanges SILO:Indonesia
Address No. 15, Jalan Boulevard Sudirman, Floor 32, Gedung Fakultas Kedokteran Universitas Pelita Harapan, Lippo Village, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
91GF Score

Get the complete analysis for FRA:2LS

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.12
GF Value